235 related articles for article (PubMed ID: 29789241)
1. Vaccines, inspiring innovation in health.
Pagliusi S; Dennehy M; Kim H;
Vaccine; 2018 Nov; 36(48):7430-7437. PubMed ID: 29789241
[TBL] [Abstract][Full Text] [Related]
2. Vaccines: Shaping global health.
Pagliusi S; Ting CC; Lobos F;
Vaccine; 2017 Mar; 35(12):1579-1585. PubMed ID: 28237501
[TBL] [Abstract][Full Text] [Related]
3. The art of partnerships for vaccines.
Pagliusi S; Che Y; Dong S
Vaccine; 2019 Sep; 37(40):5909-5919. PubMed ID: 31447125
[TBL] [Abstract][Full Text] [Related]
4. Two decades of vaccine innovations for global public good: Report of the Developing Countries' Vaccine Manufacturers Network 20th meeting, 21-23 october 2019, Rio de Janeiro, Brazil.
Pagliusi S; Dennehy M; Homma A
Vaccine; 2020 Aug; 38(36):5851-5860. PubMed ID: 32535016
[TBL] [Abstract][Full Text] [Related]
5. Developing Countries Vaccine Manufacturers Network (DCVMN): engaging to step up for vaccine discovery and access. Meeting report 2012.
Pagliusi S; Makhoana M; Datla M; Leite L; Hendriks J; Gholami A; Huang W; Gao Y; Jadhav S; Harshavardhan GV; Wu Y; Suhardono M; Homma A
Vaccine; 2013 Jun; 31(31):3111-5. PubMed ID: 23684836
[TBL] [Abstract][Full Text] [Related]
6. Better vaccines for healthier life. Part I. Conference report of the DCVMN International 14th Annual General Meeting Hanoi, Vietnam.
Pagliusi S; Rustan R; Huang W; Nguyen T;
Vaccine; 2014 Nov; 32(48):6325-9. PubMed ID: 24923636
[TBL] [Abstract][Full Text] [Related]
7. Quality vaccines for all people: Report on the 16th annual general meeting of the Developing Countries Vaccine Manufacturers' Network, 05-07th October 2015, Bangkok, Thailand.
Pagliusi S; Ting CC; Khomvilai S;
Vaccine; 2016 Jun; 34(31):3562-7. PubMed ID: 26947496
[TBL] [Abstract][Full Text] [Related]
8. Vaccines for a healthy future: 21st DCVMN Annual General Meeting 2020 report.
Pagliusi S; Hayman B; Jarrett S
Vaccine; 2021 Apr; 39(18):2479-2488. PubMed ID: 33838948
[TBL] [Abstract][Full Text] [Related]
9. Strengthening global vaccine access for adolescents and adults.
Nanni A; Meredith S; Gati S; Holm K; Harmon T; Ginsberg A
Vaccine; 2017 Dec; 35(49 Pt B):6823-6827. PubMed ID: 29122384
[TBL] [Abstract][Full Text] [Related]
10. Vaccines: New challenges, new paradigms, new opportunities: Report of the 22nd DCVMN Annual General Meeting.
Kumar Suri R; Hayman B; Prasad SD; Makhoana M; Tippoo P
Vaccine; 2022 Jun; 40(26):3495-3505. PubMed ID: 35577632
[TBL] [Abstract][Full Text] [Related]
11. Effect of donor funding for immunization from Gavi and other development assistance channels on vaccine coverage: Evidence from 120 low and middle income recipient countries.
Ikilezi G; Augusto OJ; Dieleman JL; Sherr K; Lim SS
Vaccine; 2020 Jan; 38(3):588-596. PubMed ID: 31679863
[TBL] [Abstract][Full Text] [Related]
12. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
Peny JM; Gleizes O; Covilard JP
Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
[TBL] [Abstract][Full Text] [Related]
13. Role of vaccine manufacturers in developing countries towards global healthcare by providing quality vaccines at affordable prices.
Jadhav S; Gautam M; Gairola S
Clin Microbiol Infect; 2014 May; 20 Suppl 5():37-44. PubMed ID: 24476201
[TBL] [Abstract][Full Text] [Related]
14. Developing-country vaccine manufacturers' technical capabilities can make a difference in global immunization.
Hayman B; Dennehy M
Vaccine; 2021 Aug; 39(36):5153-5161. PubMed ID: 34362602
[TBL] [Abstract][Full Text] [Related]
15. Role of Global Alliance for Vaccines and Immunization (GAVI) in Accelerating Inactivated Polio Vaccine Introduction.
Thacker N; Thacker D; Pathak A
Indian Pediatr; 2016 Aug; 53 Suppl 1():S57-S60. PubMed ID: 27771641
[TBL] [Abstract][Full Text] [Related]
16. Costs of vaccine programs across 94 low- and middle-income countries.
Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
[TBL] [Abstract][Full Text] [Related]
17. Vaccines, our shared responsibility.
Pagliusi S; Jain R; Suri RK;
Vaccine; 2015 May; 33(19):2197-2202. PubMed ID: 25749248
[TBL] [Abstract][Full Text] [Related]
18. The Developing Countries Vaccine Manufacturers' Network (DCVMN) is a critical constituency to ensure access to vaccines in developing countries.
Jadhav S; Datla M; Kreeftenberg H; Hendriks J
Vaccine; 2008 Mar; 26(13):1611-5. PubMed ID: 18294742
[TBL] [Abstract][Full Text] [Related]
19. Advancing innovation for vaccine manufacturers from developing countries: Prioritization, barriers, opportunities.
Hayman B; Bowles A; Evans B; Eyermann E; Nepomnyashchiy L; Pagliusi S
Vaccine; 2021 Feb; 39(8):1190-1194. PubMed ID: 33487466
[TBL] [Abstract][Full Text] [Related]
20. Strengthening vaccination policies in Latin America: an evidence-based approach.
Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]